[1]
|
D. R. Brown, M. May, J. M. Bradbury, M. F. Balish, M. J. Calcutt, J. I. Glass, S. Tasker, J. B. Messick, K.-E. Johansson and H. Neimark, “Genus I. Mycoplasma.,” In: N. R. Krieg, W. Ludwig, W. B. Whitman, B. P. Hedlund, B. J. Paster, J. T. Staley, N. Ward, D. R. Brown and A. Parte, Eds., Bergey’s Manual of Systematic Bacteriology, Springer, Inc., New York, 2010 pp. 575-644.
|
[2]
|
K. B. Waites and D. Talkington, “New Developments in Human Disease Due to Mycoplasmas,” In: A. Blanchard and G. F. Browning, Eds., Mycoplasmas: Molecular Biology, Pathogenicity, and Strategies for Control, Horizon Bioscience, Norfolk, 2005, pp. 289-354.
|
[3]
|
C. L. McGowin and C. Anderson-Smits, “Mycoplasma genitalium: An Emerging Cause of Sexually Transmitted Disease in Women,” PLoS Pathogens, Vol. 7, No. 5, 2011, Article ID: e1001324.
|
[4]
|
B. Larsen and J. Hwang, “Mycoplasma, Ureaplasma, and Adverse Pregnancy Outcomes: A Fresh Look,” Infectious Diseases in Obstetrics and Gynecology, Vol. 2010, 2010, Article ID: 521921. doi:10.1155/2010/521921
|
[5]
|
R. M. Viscardi, “Ureaplasma Species: Role in Diseases of Prematurity,” Clinics in Perinatology, Vol. 37, No. 2, 2010, pp. 393-409. doi:10.1016/j.clp.2009.12.003
|
[6]
|
R. M. Viscardi, W. M. Manimtim, C. C. Sun, L. Duffy and G. H. Cassell, “Lung Pathology in Premature Infants with Ureaplasma urealyticum Infection,” Pediatric and Developmental Pathology Vol. 5, No. 2, 2002, pp. 141-150.
|
[7]
|
M. A. De Francesco, S. Caracciolo, C. Bonfanti and N. Manca, “Incidence and Antibiotic Susceptibility of Mycoplasma hominis and Ureaplasma urealyticum Isolated in Brescia, Italy, over 7 Years,” Journal of Infection and Chemotherapy, 2012.
|
[8]
|
R. Krausse and S. Schubert, “In-Vitro Activities of Tetracyclines, Macrolides, Fluoroquinolones and Clindamycin against Mycoplasma hominis and Ureaplasma ssp. Isolated in Germany over 20 Years,” Clinical Microbiology and Infection, Vol. 16, No. 11, 2010, pp. 1649-1655.
doi:10.1111/j.1469-0691.2010.03155.x
|
[9]
|
Y. Shimada, T. Deguchi, K. Nakane, T. Masue, M. Yasuda, S. Yokoi, S. Ito, M. Nakano and H. Ishiko, “Emergence of Clinical Strains of Mycoplasma genitalium Harbouring Alterations in ParC Associated with Fluoroquinolone Resistance,” International Journal of Antimicrobial Agents, Vol. 36, No. 3, 2010, pp. 255-258.
doi:10.1016/j.ijantimicag.2010.05.011
|
[10]
|
Y. Shimada, T. Deguchi, K. Nakane, M. Yasuda, S. Yo-koi, S. Ito, M. Nakano and H. Ishiko, “Macrolide Resistance-Associated 23S rRNA Mutation in Mycoplasma genitalium, Japan,” Emerging Infectious Diseases, Vol. 17, No. 6, 2011, pp. 1148-1150.
doi:10.3201/eid1706.101055
|
[11]
|
Y. Shimada, T. Deguchi, Y. Yamaguchi, M. Yasuda, K. Nakane, S. Yokoi, S. Ito, M. Nakano and H. Ishiko, “gyrB and parE Mutations in Urinary Mycoplasma genitalium DNA from Men with Non-Gonococcal Urethritis,” International Journal of Antimicrobial Agents, Vol. 36, No. 5, 2010, pp. 477-478. doi:10.1016/j.ijantimicag.2010.07.013
|
[12]
|
S. L. Iverson-Cabral, S. G. Astete, C. R. Cohen and P. A. Totten, “mgpB and mgpC Sequence Diversity in Mycoplasma Genitalium Is Generated by Segmental Reciprocal Recombination with Repetitive Chromosomal Sequences,” Molecular Microbiology, Vol. 66, No. 1, 2007, pp. 55-73. doi:10.1111/j.1365-2958.2007.05898.x
|
[13]
|
S. L. Iverson-Cabral, S. G. Astete, C. R. Cohen, E. P. Ro- cha and P. A. Totten, “Intrastrain Heterogeneity of the mgpB Gene in Mycoplasma genitalium Is Extensive in Vitro and in Vivo and Suggests That Variation Is Generated via Recombination with Repetitive Chromosomal Sequences,” Infection and Immunity, Vol. 74, No. 7, 2006, pp. 3715-3726. doi:10.1128/IAI.00239-06
|
[14]
|
K. Pandelidis, K. A. McCarthy, K. L. Chesko and R. M. Viscardi, “Role of Biofilm Formation in Ureaplasma Antibiotic Susceptibility and Development of Bronchopulmonary Dysplasia in Preterm Neonates,” Pediatric Infectious Disease Journal, Vol. 32, No. 4, 2013, pp. 394-398.
|
[15]
|
L. J. Teng, X. Zheng, J. I. Glass, H. L. Watson, J. Tsai and G. H. Cassell, “Ureaplasma urealyticum Biovar Specificity and Diversity Are Encoded in Multiple-Banded Antigen Gene,” Journal of Clinical Microbiology, Vol. 32, No. 6, 1994, pp. 1464-1469.
|
[16]
|
V. Paralanov, J. Lu, L. B. Duffy, D. M. Crabb, S. Shrivastava, B. A. Methé, J. Inman, S. Yooseph, L. Xiao, G. H. Cassell, K. B. Waites and J. I. Glass, “Comparative Genome Analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum Strains,” BMC Microbiology, Vol. 12, 2012, p. 88.
|
[17]
|
L. E. Manhart, S. B. Mostad, J. M. Baeten, S. G. Astete, K. Mandaliya and P. A. Totten, “High Mycoplasma Genitalium Organism Burden Is Associated with Shedding of HIV-1 DNA from the Cervix,” Journal of Infectious Diseases, Vol. 197, No. 5, 2008, pp. 733-736.
doi:10.1086/526501
|
[18]
|
C. L. McGowin, R. S. Annan, A. J. Quayle, S. J. Greene, L. Ma, M. M. Mancuso, D. Adegboye and D. H. Martin, “Persistent Mycoplasma genitalium Infection of Human Endocervical Epithelial Cells Elicits Chronic Inflammatory Cytokine Secretion,” Infection and Immunity, Vol. 80, No. 11, 2012, pp. 3842-3849.
doi:10.1128/IAI.00819-12
|